Effect of Phacoemulsification on Ocular Blood Flow in Human

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
yin ying zhao, Wenzhou Medical College
ClinicalTrials.gov Identifier:
NCT01305005
First received: February 25, 2011
Last updated: July 16, 2012
Last verified: July 2012
  Purpose
  • To investigate ocular haemodynamics after phacoemulsification surgery
  • To evaluate the influence in people with different autoregulation of ocular blood flow

Condition
Cataract
Hypertension
Diabetes

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: To Investigate Ocular Haemodynamics After Phacoemulsification Surgery

Resource links provided by NLM:


Further study details as provided by Wenzhou Medical University:

Enrollment: 58
Study Start Date: March 2011
Study Completion Date: May 2012
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
hyperpiesia
patients who underwent phacoemulsification surgery with hyperpiesia
diabetes mellitus
patients who underwent phacoemulsification surgery with diabetes mellitus
hyperpiesia and diabetes mellitus
patients who underwent phacoemulsification surgery with hyperpiesia and diabetes mellitus

  Eligibility

Ages Eligible for Study:   60 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

patients who underwent phacoemulsification surgery in Eye Hospital of Wenzhou Medical College

Criteria

Inclusion Criteria:

  • age-related cataract
  • no complications during surgery

Exclusion Criteria:

  • complications during surgery
  • have other complications
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01305005

Locations
China, Zhejiang
Eye Hospital of Wenzhou Medical College
Wenzhou, Zhejiang, China, 325027
Sponsors and Collaborators
yin ying zhao
Investigators
Principal Investigator: qu jia, MD Wenzhou Medical University
  More Information

No publications provided

Responsible Party: yin ying zhao, Yin Ying Zhao, Wenzhou Medical College
ClinicalTrials.gov Identifier: NCT01305005     History of Changes
Other Study ID Numbers: WZMC2011BNZYJ
Study First Received: February 25, 2011
Last Updated: July 16, 2012
Health Authority: China: State Administration of Traditional Chinese Medicine of the People's Republic of China

Keywords provided by Wenzhou Medical University:
blood flow

Additional relevant MeSH terms:
Hypertension
Cataract
Vascular Diseases
Cardiovascular Diseases
Lens Diseases
Eye Diseases

ClinicalTrials.gov processed this record on August 20, 2014